Exagen (XGN) PT Raised to $9 at Roth/MKM
Tweet
Share
E-mailGet Alerts XGN Hot Sheet
Price: $8.41 +6.86%
Rating Summary:
9 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
9 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
Roth/MKM analyst Max Masucci raised the price target on Exagen (NASDAQ: XGN) to $9.00 (from $8.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Nscale files for IPO, seeks NYSE listing under ticker NSCL
- First Carolina Financial Services CFO to retire in January 2027
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
